Literature DB >> 16867164

Number-needed-to-treat (NNT)--needs treatment with care.

Palle Mark Christensen1, Ivar Sønbø Kristiansen.   

Abstract

The "number-needed-to-treat" (NNT) was introduced about 15 years ago and has gained widespread use. It has been claimed to be "easy to understand" and gives "intuitive meaning". When used to measure the effectiveness of interventions targeting chronic disease processes e.g. atherosclerosis and osteoporosis, NNT (as well as relative and absolute risk reduction) does not capture the crucial time component, a fact that has important consequences: NNT varies over time, it may not mean that adverse events (fractures, myocardial infarctions etc.) are avoided, but simply that they are postponed. Finally, empirical studies indicate that lay people and doctors misunderstand NNT. We recommend that NNT be used with considerable care. There is probably no single effect measure that is able to convey all necessary information.

Entities:  

Mesh:

Year:  2006        PMID: 16867164     DOI: 10.1111/j.1742-7843.2006.pto_412.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  16 in total

1.  The "number needed to treat" turns 20--and continues to be used and misused.

Authors:  Finlay A McAlister
Journal:  CMAJ       Date:  2008-09-09       Impact factor: 8.262

Review 2.  An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.

Authors:  Anil N Makam; Oanh K Nguyen
Journal:  Circulation       Date:  2017-01-10       Impact factor: 29.690

Review 3.  Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock.

Authors:  Brenda Ng Andriolo; Regis B Andriolo; Reinaldo Salomão; Álvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2017-01-18

Review 4.  Post-traumatic osteoarthritis: from mouse models to clinical trials.

Authors:  Christopher B Little; David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2013-05-21       Impact factor: 20.543

5.  Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Kenneth W Kenyon; John G F Cleland; Michel Komajda; Willem J Remme; Christian Torp-Pedersen; Marco Metra; Philip A Poole-Wilson
Journal:  Eur J Heart Fail       Date:  2009-01-22       Impact factor: 15.534

Review 6.  Topical treatments for scalp psoriasis.

Authors:  Justin Gabriel Schlager; Stefanie Rosumeck; Ricardo Niklas Werner; Anja Jacobs; Jochen Schmitt; Christoph Schlager; Alexander Nast
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

7.  Re-interpreting conventional interval estimates taking into account bias and extra-variation.

Authors:  Michael Höfler; Shaun R Seaman
Journal:  BMC Med Res Methodol       Date:  2006-10-16       Impact factor: 4.615

8.  Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study.

Authors:  Gian Galeazzo Riario-Sforza; Cristoforo Incorvaia; Fulvia Paterniti; Laura Pessina; Roberta Caligiuri; Chiara Pravettoni; Fabiano Di Marco; Stefano Centanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01

Review 9.  Ivermectin and permethrin for treating scabies.

Authors:  Stefanie Rosumeck; Alexander Nast; Corinna Dressler
Journal:  Cochrane Database Syst Rev       Date:  2018-04-02

10.  Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?

Authors:  Henrik Stovring; Dorte Gyrd-Hansen; Ivar S Kristiansen; Jorgen Nexoe; Jesper B Nielsen
Journal:  BMC Med Inform Decis Mak       Date:  2008-06-19       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.